在治疗口腔和面瘤的治疗方法中利用BRAF突变
Jing-Rui Yi1, Nian-Nian Zhong1, Hao Lin1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China.
Journal of stomatology, oral and maxillofacial surgery
|March 31, 2024
概括
用达布拉费尼布和特拉美丁尼布准BRAF突变为下骨髓母细胞瘤提供了一个有前途,安全和有效的新辅助疗法,有可能保护器官并改善口腔癌患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 在口腔外科手术.
背景情况:
- 口腔和面瘤由于高复发率和复杂的手术治疗,存在重大挑战.
- 的复杂解剖学使治疗复杂化,并影响患者的生活质量.
- 药理干预越来越多地被探索,以尽量减少侵入性的外科手术程序.
研究的目的:
- 研究向BRAF突变,特别是V600E突变在口腔和面瘤中的有效性.
- 评估一种新辅助疗法,包括达布拉费尼布和特拉美丁尼布用于BRAF突变细胞母细胞瘤.
- 评估器官保存和改善患者治疗结果的潜力.
主要方法:
- 在口腔和大面部瘤中识别BRAF V600E突变.
- 用达布拉费尼布和特拉美替尼布进行新辅助疗法.
- 在下骨髓母细胞瘤治疗安全性,疗效和器官保存的评估.
主要成果:
- BRAF V600E突变是某些口腔和面瘤的常见驱动因素,包括乳腺母细胞瘤.
- 用达布拉费尼布和特拉美替尼布进行的新辅助治疗显示出有前途的安全性和疗效.
- 向治疗促进了下骨髓母细胞瘤患者的器官保存.
结论:
- 向BRAF突变是管理特定口腔和口面瘤的关键策略.
- 新辅助剂达布拉费尼布和特拉美丁尼布为BRAF突变细胞母细胞瘤提供了一种可行的器官节约方法.
- 这种分子向治疗有望显著改善口腔瘤学患者的治疗结果.
更多相关视频
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
2.9K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.7K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K